Your browser doesn't support javascript.
loading
Narcolepsy: Clinical Feature, Diagnosis and Treatment / 수면정신생리
Article en Ko | WPRIM | ID: wpr-214074
Biblioteca responsable: WPRO
ABSTRACT
Narcolepsy is a central neurologic system disease. It begins early in life with disabling symptoms including excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic hallucination and nocturnal sleep fragmentation. Patient with typical symptoms of narcolepsy is diagnosed by objective data from nocturnal polysomnography and multiple sleep latency tests. Narcolepsy is controlled with various medications. Nowadays, modafinil with favorable side effects profiles compared with traditional stimulant is mainly used. Gamma hydroxyl butyrate is effective in cataplexy. Cataplexy is also controlled with antidepressant such as Venlafaxine, SSRI, and TCA. As the knowledge of pathophysiology of narcolepsy expands, new treatment including immunological method, application of hypocretin and histamine systems have been tried.
Asunto(s)
Palabras clave
Texto completo: 1 Índice: WPRIM Asunto principal: Privación de Sueño / Compuestos de Bencidrilo / Neuropéptidos / Butiratos / Histamina / Cataplejía / Polisomnografía / Parálisis del Sueño / Ciclohexanoles / Péptidos y Proteínas de Señalización Intracelular Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: Ko Revista: Sleep Medicine and Psychophysiology Año: 2010 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Asunto principal: Privación de Sueño / Compuestos de Bencidrilo / Neuropéptidos / Butiratos / Histamina / Cataplejía / Polisomnografía / Parálisis del Sueño / Ciclohexanoles / Péptidos y Proteínas de Señalización Intracelular Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: Ko Revista: Sleep Medicine and Psychophysiology Año: 2010 Tipo del documento: Article